Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Most adverse drug reactions unreported, study finds
The researchers also want regulators to make reporting quicker and easier.
Researchers urge vets to report suspected cases.

Veterinary professionals are being encouraged to report suspected adverse drug reactions, after a new study found that the vast majority were not reported.

Researchers from the University of Liverpool reviewed more than 10,000 electronic health records from the Small Animal Veterinary Surveillance Network (SAVSNET). They found 827 cases of suspected adverse drug reactions, of which around 90 per cent went unreported.

Heather Davies, lead author of the study, explained: “It has long been thought that adverse drug reactions are under-reported. This work used real world evidence from first opinion practice to be the first publication that confirms this suspicion.”

Free-text clinical narratives of consultations stored in SAVSNET were screened for the phrases ‘adverse drug reaction’ and ‘side effect’.

The researchers then analysed the records to determine the seriousness and expectedness of the reaction, the suspected product, and whether it had been reported to the Veterinary Medicines Directorate (VMD) or the relevant marketing authorisation holder.

Most of the cases involved dogs and 70 per cent were listed as ‘expected’. Reactions which were not expected were more likely to be reported. The study also found that there was no correlation between the clinical severity of the reaction and how likely to was to be reported.

Dr Davies added: “As adverse drug reaction reporting rate is directly linked to the regulator's ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.

“It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”

The study, which received funding from BSAVA PetSavers and the VMD, has been published in the Journal of Small Animal Practice.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.